Fig. 4: Waterfall plot indicating the Best Percentage Change in sum of target lesion diameters for patients in the B2 cohorts.
From: A phase II trial of mTORC1/2 inhibition in STK11 deficient non small cell lung cancer
Per-protocol participants who discontinued without having returned a measurement are included on the left of the plot with a default measurement of +100%.
